Kathy Waldman

Kathy Waldman has more than 31 years of experience in support of the Red Cross blood program. She was named Senior Vice President, Quality & Regulatory Affairs for Biomedical Services in August, 2010 and served in this capacity until her successor took over in January 2017. After demonstrating five years of sustained compliance, the Red Cross vacated the FDA Consent Decree under Kathy’s leadership of Q&RA. Kathy is now serving as Senior Vice President, Special Projects until her planned retirement at the end of 2017.